Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study

• Egile Nagusiak: Min-Lan Tsai (Egilea), Hsiu-Chen Lin (Egilea), Chiung-Hui Yen (Egilea), Jung-Tzu Ku (Egilea), Shian-Ying Sung (Egilea), Hsi Chang (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2022-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

(1) Background: Cysteinyl leukotriene receptor antagonists (LTRAs), including montelukast and zafirlukast, are FDA-approved for treating pediatric asthma and allergic diseases. Tourette syndrome (TS), a common neuropsychiatric disorder in children, is associated with allergic diseases and asthma. In...